Subject: RE: Your JHep Submission--ACCEPTED (COI needed)
From: Nato Kvernadze <[email-masked]>
To: Tamar Gabunia <[email-masked]>
Date: Wed, 26 Jun 2019 10:06:34 +0000

From: Tamar Gabunia
Sent: ოთხშაბათი, 26 ივნისი, 2019 12:37
To: Nato Kvernadze <[email-masked]>
Subject: Fwd: Your JHep Submission--ACCEPTED (COI needed)
Importance: High

ნატა დანართი ამომიბეჭდე და რომ მოვალ მოვაწერ ხელს.

Sent from my Samsung Galaxy smartphone.

-------- Original message --------

From: "Nasrullah, Muazzam (CDC/DDID/NCHHSTP/DVH)" <[email-masked]>

Date: 6/25/19 9:36 PM (GMT+04:00)

To: "Averhoff, Francisco (CDC/DDID/NCHHSTP/DVH)" <[email-masked]>, Jeffrey Lazarus <[email-masked]>, David Sergeenko <[email-masked]>, Massimo Colombo <[email-masked]>, "Gamkrelidze, Amiran (CDC ncdc.ge)" <[email-masked]>, Tengiz Tsertsvadze <[email-masked]>, Maia Butsashvili <[email-masked]>, [email-masked], Lali Sharvadze <[email-masked]>, Margaret Hellard <[email-masked]>, Stefano Gnes <[email-masked]>, Tamar Gabunia <[email-masked]>

Cc: "Nasrullah, Muazzam (CDC/DDID/NCHHSTP/DVH)" <[email-masked]>

Subject: FW: Your JHep Submission--ACCEPTED (COI needed)

Dear all,

I am happy to inform you that our Editorial "Excellence in Viral Hepatitis Elimination - Lessons from Georgia" is ACCEPTED for publication in Journal of Hepatology. However, its MANDATORY that every author must complete their conflict of interest (COI) forms (attached) before our Editorial can be published. I look forward to receiving COI from each of you soon. I want to thank everyone for their contribution and support without which this publication would have not been possible.

Best regards,

Muazzam

------------------------------------------------------

Muazzam Nasrullah, MD, MPH, PhD

Global Health Unit | Office of the Director

Division of Viral Hepatitis

National Center for HIV, Hepatitis, STD & TB Prevention

Centers for Disease Control and Prevention (CDC)

1600 Clifton Road, Mailstop G-37, Atlanta, GA 30329

Office: +1 404 639 3271; Fax: +1 404 718 8588

Email: [email-masked]

------------------------------------------------------

-----Original Message-----

From: [email-masked] <[email-masked]>

Sent: Thursday, June 20, 2019 6:04 AM

To: Nasrullah, Muazzam (CDC/DDID/NCHHSTP/DVH) <[email-masked]>

Cc: [email-masked]

Subject: Your Submission

Ref: JHEPAT-D-19-01152

Title: Excellence in Viral Hepatitis Elimination - Lessons from Georgia Article Type: Editorial Journal of Hepatology

Dear Dr. Nasrullah,

We are pleased to inform you that your paper "Excellence in Viral Hepatitis Elimination - Lessons from Georgia", has been accepted for publication in the Journal of Hepatology.

Within approximately 3-5 weeks you will receive a PDF proof of your article, along with information on ordering article reprints.

In order to proceed with the production of your manuscript, may we ask you to print and sign both the Copyright Statement and Drug Declaration Disclosure forms, as well as the Permission to re-design graphics form, and send them back to the Editorial Office either by fax or e-mail. Please be aware that we cannot publish your manuscript until we have received these forms.

Click on the link below to download the form: http://ees.elsevier.com/jhepat/img/Copyright.pdf

Alternatively, the form can also be accessed in the main page (http://www.ees.elsevier.com/jhepat/) under author information, in the copyright link.

If your institute has any plans to issue a press release about your publication in Journal of Hepatology, I would be grateful to be informed. To see examples of press releases issued by the journal, please visit http://www.journal-of-hepatology.eu/content/pressreleases.

Congratulations on your upcoming publication, and we thank you for submitting your work to the Journal of Hepatology.

Yours sincerely,

Thomas  Berg

Co-Editor

Rajiv Jalan

Editor-In-Chief

Journal of Hepatology

******************************************

For further assistance, please visit our customer support site at http://help.elsevier.com/app/answers/list/p/7923. Here you can search for solutions on a range of topics, find answers to frequently asked questions and learn more about EES via interactive tutorials. You will also find our 24/7 support contact details should you need any further assistance from one of our customer support representatives.